Ad is loading...
HEMTX
Price
$9.18
Change
-$0.06 (-0.65%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

HEMTX vs RNWFX

Header iconHEMTX vs RNWFX Comparison
Open Charts HEMTX vs RNWFXBanner chart's image
Janus Henderson Emerging Markets T
Price$9.18
Change-$0.06 (-0.65%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
HEMTX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HEMTX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HEMTX is a Sell and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. HEMTX (30.2M). RNWFX pays higher dividends than HEMTX: RNWFX (1.51) vs HEMTX (0.40). HEMTX was incepted earlier than RNWFX: HEMTX (7 years) vs RNWFX (23 years). HEMTX is a more actively managed with annual turnover of: 63.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than HEMTX: RNWFX (250) vs HEMTX (2500). RNWFX annual gain was more profitable for investors over the last year : 11.54 vs. HEMTX (5.48). RNWFX return over 5 years is better than : 17.17 vs. HEMTX (5.38).
HEMTXRNWFXHEMTX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years23 years-
Gain YTD3.2627.09946%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets30.2M60.9B0%
Annual Yield % from dividends0.401.5126%
Returns for 1 year5.4811.5447%
Returns for 3 years-23.00-14.55158%
Returns for 5 years5.3817.1731%
Returns for 10 yearsN/A41.00-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics